NLS Pharmaceutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch NLSP and buy or sell other stocks, ETFs, and their options commission-free!About NLSP
NewCelX Ltd. is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company is headquarter in Kloten, Switzerland.
CEORonen Twito
CEORonen Twito
Employees3
Employees3
HeadquartersKloten, Zurich
HeadquartersKloten, Zurich
Founded
Founded
Employees3
Employees3
NLSP Key Statistics
Market cap1.66M
Market cap1.66M
Price-Earnings ratio-0.21
Price-Earnings ratio-0.21
Dividend yield—
Dividend yield—
Average volume41.99K
Average volume41.99K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$33.70
52 Week high$33.70
52 Week low$3.06
52 Week low$3.06
Stock Snapshot
NLS Pharmaceutics(NLSP) stock is priced at $4.01, giving the company a market capitalization of 1.66M. It carries a P/E multiple of -0.21.
NLS Pharmaceutics(NLSP) stock opened on 2025-12-04 at —. The price climbed to — and dipped to —.
NLS Pharmaceutics(NLSP) shares are trading with a volume of 0, against a daily average of 41.99K.
In the last year, NLS Pharmaceutics(NLSP) shares hit a 52-week high of $33.70 and a 52-week low of $3.06.
In the last year, NLS Pharmaceutics(NLSP) shares hit a 52-week high of $33.70 and a 52-week low of $3.06.
People also own
Based on the portfolios of people who own NLSP. This list is generated using Robinhood data, and it’s not a recommendation.